Impact of induction agent selection on rejection, allograft function, and survival in kidney transplant recipients [0.03%]
诱导药物选择对肾移植受者的排斥反应、移植物功能和生存的影响
Mohamad Saria Aldarwish,Wassim Toomah,Amro Idilbi et al.
Mohamad Saria Aldarwish et al.
Background: Kidney allograft rejection, driven by the recipient's immune response to non-self-HLA, remains a key barrier to kidney allograft survival. Induction therapy seeks to suppress early alloimmunity and reduce reje...
mRNA vaccine for human cytomegalovirus in immunocompromised hosts: An immunoinformatics approach [0.03%]
免疫受损宿主的人巨细胞病毒mRNA疫苗的免疫信息学方法研究
Muhammad Zeeshan Ahmed,Sana Dilbar,Syeda Masooma Zahra Bukhari et al.
Muhammad Zeeshan Ahmed et al.
Human cytomegalovirus (HCMV) poses a significant threat to immunocompromised individuals, including transplant recipients, neonates, and patients with immunosuppression. Despite extensive research, no effective vaccine exists-especially one...
Human leukocyte antigen-C*08 increases the risk of BK virus viremia in kidney transplant recipients [0.03%]
人白细胞抗原-C*08增加肾移植受者的BK病毒血症风险
Marie-Pier Thivierge,Stéphanie Béland,Olivier Désy et al.
Marie-Pier Thivierge et al.
BK virus (BKV) infection can cause graft loss in kidney transplant recipients. Several factors increase the risk of infection, including high level of immunosuppression, older age, and human leukocyte antigen (HLA) mismatch. The primary fun...
Novel, short-course, low-dose total lymphoid irradiation (TLI) post heart transplant for recalcitrant rejection - A single centre experience [0.03%]
新型短程小剂量全身淋巴照射（TLI）在心脏移植后难治性排斥反应中的应用——一项单中心经验报告
Felicity Lee,B N Clare Fazackerley,Tee S Lim et al.
Felicity Lee et al.
Background: A previous small study (2007) of patients who received short-course, low-dose total lymphoid irradiation (sTLI) as treatment for recalcitrant cardiac rejection post-heart transplantation (HTx) reported good tr...
Conversion to belatacept-based immunosuppression as a calcineurin sparing regimen in lung transplant: A multi-institutional retrospective study [0.03%]
贝拉西普为基础的免疫抑制作为肺移植后的钙调神经磷酸酶减省方案：一项多中心回顾性研究
Moustafa Younis,Cecelia M Miller,Christopher I Mederos et al.
Moustafa Younis et al.
Background: Calcineurin inhibitor (CNI) related kidney dysfunction is common and associated with worse outcomes after lung transplantation (LTx). To mitigate that risk, belatacept use in a CNI-sparing regimen is an altern...
Temporal dynamics of cPRA levels and their categorical impact on waitlist longevity in Ecuadorian kidney transplant candidates: A 2011-2022 Nationwide cohort analysis [0.03%]
厄瓜多尔肾移植候选人的cPRA水平的动态变化及其对等待时间的影响：一项2011-2022年全国队列分析
David Garrido,Verónica Jeréz,Jorge Huertas
David Garrido
Background: Chronic kidney disease is a major public health concern for which kidney transplantation offers the best survival benefit. Patients with high calculated panel-reactive antibody (cPRA) levels often face extende...
Relation between monocyte to high-density lipoprotein cholesterol ratio and prognosis in recipients after liver transplantation [0.03%]
肝移植受者单核细胞与高密度脂蛋白胆固醇比值与预后的关联性分析
Serafettin Okutan,Hasan Saritas,Serdar Saritas et al.
Serafettin Okutan et al.
Background: The end-stage liver diseases require liver transplantation as the life-saving solution. It is known that monocytes/macrophages and high-density lipoprotein cholesterol (HDLC) have important contributions to th...
Smart transplant+: A HyCARE hybrid AI-cloud framework for intelligent donor-recipient matching, workflow automation, and post-transplant optimization [0.03%]
智能移植+: 一种HyCARE混合AI-云框架，用于智能化供体-受体匹配、工作流程自动化和移植后优化
Winner Pulakhandam,Archana Chaluvadi,Visrutatma Rao Vallu et al.
Winner Pulakhandam et al.
Organ transplantation is a life-saving medical intervention to reverse end-stage organ failure. Despite its life-saving potential, organ transplantation faces inefficiencies like organ shortages, long wait times, and rejection risks due to ...
Immune mediators as therapeutic targets in GvHD; cytokines, growth factors, chemokines, and co-stimulation /co-inhibition [0.03%]
免疫介质作为GvHD治疗靶点：细胞因子、生长因子、趋化因子和共刺激/共抑制分子
Amir Rastegari,Fatemeh Mohebbi
Amir Rastegari
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) and emerging allogeneic T cell-based immunotherapies offer curative potential for hematologic malignancies, solid tumors, and selected non-malignant disorders through graft-vers...
Prevalence and determinants of frailty-sarcopenia comorbidity in hospitalized patients undergoing liver transplantation for hepatic echinococcosis [0.03%]
肝棘球蚴病受者住院患者的衰弱-肌少症共病的流行及决定因素
Sujun Wang,Huanhuan Wei,Yiliyaer Aihemaiti et al.
Sujun Wang et al.
Objective: The aim of this study was to examine the prevalence and influencing factors of comorbid frailty and sarcopenia in hospitalized patients with hepatic echinococcosis undergoing liver transplantation, thereby prov...